Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 13.95 0.00% 0.00
TGTX closed up 1.09 percent on Tuesday, June 19, 2018, on 89 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical TGTX trend table...

Date Alert Name Type % Chg
Jun 19 Crossed Above 50 DMA Bullish 0.00%
Jun 19 Bollinger Band Squeeze Range Contraction 0.00%
Jun 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.09%
Jun 18 Bullish Engulfing Bullish 1.09%
Jun 18 Bollinger Band Squeeze Range Contraction 1.09%
Jun 18 Inside Day Range Contraction 1.09%
Jun 18 Oversold Stochastic Weakness 1.09%
Jun 15 50 DMA Resistance Bearish 1.82%
Jun 15 Bollinger Band Squeeze Range Contraction 1.82%
Jun 15 Doji - Bullish? Reversal 1.82%

Older signals for TGTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Is TGTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.35
52 Week Low 7.25
Average Volume 953,772
200-Day Moving Average 11.7073
50-Day Moving Average 13.8344
20-Day Moving Average 13.825
10-Day Moving Average 13.81
Average True Range 0.6675
ADX 13.81
+DI 18.48
-DI 18.16
Chandelier Exit (Long, 3 ATRs ) 13.9975
Chandelier Exit (Short, 3 ATRs ) 15.1025
Upper Bollinger Band 14.7275
Lower Bollinger Band 12.9225
Percent B (%b) 0.57
BandWidth 13.056058
MACD Line -0.0094
MACD Signal Line -0.0032
MACD Histogram -0.0062
Fundamentals Value
Market Cap 869.23 Million
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -7.15
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.70
Resistance 3 (R3) 14.63 14.32 14.58
Resistance 2 (R2) 14.32 14.13 14.35 14.53
Resistance 1 (R1) 14.13 14.01 14.23 14.20 14.49
Pivot Point 13.82 13.82 13.86 13.85 13.82
Support 1 (S1) 13.63 13.63 13.73 13.70 13.41
Support 2 (S2) 13.32 13.51 13.35 13.37
Support 3 (S3) 13.13 13.32 13.33
Support 4 (S4) 13.20